Congratulations to the ACSR’s Dr. Alanna Maguire whose work was featured in a NanoString Technologies, Inc. webinar showcasing how Rosalind® was used to identify novel markers and potential therapeutic targets in HIV infected individuals. Register for an encore of the webinar by clicking on the link below!
Nanostring DLBCL Webinar, February 2, 2021
Title: A ROSALIND® Case Study: Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B-cell Lymphoma (DLBCL) subtype
Date: Tuesday, February 02, 2021
Time: 10:00 AM Pacific Standard Time
Duration: 40 minutes